Ropes & Gray won an impressive appellate victory for clients Becton Dickinson & Co. and Nova Biomedical Corp. on Monday, January 25 when the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. affirmed that the two biomedical companies had not infringed any of four different patents on diabetes monitoring technology asserted by Abbott Laboratories. The Court of Appeals also affirmed that three of those patents had claims that were either invalid and/or unenforceable. Abbott had sought more than $80 million in damages based on Becton Dickinson and Nova's manufacture and sale of glucose monitors and test strips for diabetics.
The appellate court decision in Therasense, Inc. and Abbott Laboratories v. Becton Dickinson & Company and Nova Biomedical Corporation puts an end to the nearly six-year litigation dispute where Ropes & Gray systematically dismantled Abbott’s patent claims in a series of summary judgment motions, followed by back-to-back bench and jury trials.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.